| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 20, 2025 | Dorman Products, Inc. | Director | Sell | 52.5 | -46 | -0.47% | ✗ | $6.1K |
| Jun 21, 2024 | Jun 25, 2024 | Athira Pharma, Inc. | Director | Buy | 95.0 | +42,400 | 110.66% | ✗ | $100.1K |
| May 17, 2024 | May 21, 2024 | Dorman Products, Inc. | Director | Sell | 50.0 | -47 | -0.56% | ✗ | $4.3K |
| May 18, 2023 | May 22, 2023 | Dorman Products, Inc. | Director | Sell | 50.0 | -38 | -0.55% | ✗ | $3.3K |
| Dec 2, 2022 | Dec 6, 2022 | Athira Pharma, Inc. | Director | Buy | 95.0 | +30,000 | 360.79% | ✗ | $98.7K |
| May 25, 2022 | May 27, 2022 | Dorman Products, Inc. | Director | Sell | 50.0 | -33 | -0.57% | ✗ | $3.2K |
| Mar 31, 2022 | Apr 1, 2022 | Athira Pharma, Inc. | Director | Buy | 95.0 | +8,000 | 2539.68% | ✗ | $104.9K |
| May 13, 2021 | May 17, 2021 | Dorman Products, Inc. | Director | Sell | 50.0 | -44 | -0.93% | ✗ | $4.5K |
| Dec 22, 2020 | Jan 8, 2021 | Athira Pharma, Inc. | Director | Buy | 90.0 | +315 | 100.00% | ✗ | $10K |
| Jul 2, 2020 | Jul 6, 2020 | Dorman Products, Inc. | Director | Sell | 50.0 | -36 | -0.76% | ✗ | $2.4K |
| Jul 1, 2019 | Jul 3, 2019 | Dorman Products, Inc. | Director | Sell | 90.0 | +1,117 | 50.29% | ✗ | $3.6K |